A Medical Device Daily

Hanger Orthopedic Group (Bethesda, Maryland) reported a new management team, led by President Jeff Martin, for its wholly owned subsidiary, Innovative Neurotronics (IN).

Conrad Kufta, MD, has been named director of clinical development. A neurosurgeon and specialist in the surgical treatment of epilepsy, Kufta previously served as senior staff neurosurgeon and medical officer in the surgical neurology branch of the National Institutes of Health and senior staff fellow in the surgical neurology branch of the National Institute of Neurological Disorders and Stroke.

Joseph Moser will serve as IN's director of product development and engineering. Moser has more than 30 years of engineering experience, and has held numerous management positions at companies such as SnapShopper, Sabratek and Information Resources.

Fayyaz Memon has been named director of quality and manufacturing. Memon has held leadership positions at Johnson & Johnson, SmithKline Beecham, Digene and MQS.

Pete Escallier will serve as director of marketing. With a specialty in medical device marketing, Escallier led the introduction of new products featuring proprietary technology and managed existing products to higher levels of market share for companies such as Medtronic MiniMed, Applied Medical, CompuMed, American Hydro-Surgical and Edwards Lifesciences.

Carlo Luetto has been named director of sales. Luetto has 25 years' experience selling medical devices and drug delivery systems for American Medical Systems, Medtron-ic MiniMed and Caremark / Home Health Care.

Deanna Fish and Mary-Kate Ennis will serve as directors of clinical support for IN. Fish, a prosthetist/orthotist, has 20 years' experience in patient care, clinical training and product development. An orthotist, Ennis has cared for patients at Children's Healthcare of Atlanta and Connecticut Children's Medical Center.

Hanger Orthopedic Group is a provider of orthotic and prosthetic patient care services, organized into four units. The IN unit introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide.